Cargando…
Addressing intra-tumoral heterogeneity and therapy resistance
In the last several years, our appreciation of intra-tumoral heterogeneity has greatly increased due to accumulating evidence for the co-existence of genetically and epigenetically divergent cancer cells residing in different microenvironments within a tumor. Herein, we review recent literature disc...
Autores principales: | Rybinski, Brad, Yun, Kyuson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342165/ https://www.ncbi.nlm.nih.gov/pubmed/27608848 http://dx.doi.org/10.18632/oncotarget.11875 |
Ejemplares similares
-
Breast cancer intra-tumor heterogeneity
por: Martelotto, Luciano G, et al.
Publicado: (2014) -
Cancer Stem Cells, not Bulk Tumor Cells, Determine Mechanisms of Resistance to SMO Inhibitors
por: George, Joshy, et al.
Publicado: (2022) -
Intra-patient intra-tumoral immune heterogeneity is evident at progression on targeted therapy and immunotherapy for melanoma
por: Reuben, Alexandre, et al.
Publicado: (2014) -
Collaborative intra-tumor heterogeneity detection
por: Khakabimamaghani, Sahand, et al.
Publicado: (2019) -
Intra-tumor heterogeneity: lessons from microbial evolution and clinical implications
por: de Bruin, Elza C, et al.
Publicado: (2013)